Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone as Adjunctive Therapy for Pulmonary TB and HIV Co-infection
NCT00414414Phase 3Withdrawn
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Feb 2007
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Tuberculosis (TB) comparing Prednisone with Placebo (2 arms). Primary endpoint: 30-day survival. Planned start Feb 2007; status: withdrawn.
02
Drugs
prednisone
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00414414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414414.